Breast Comprehensive Panel NGS Genetic Test
Cost: AED 4400.0
Test Name
Breast Comprehensive Panel NGS Genetic DNA Test
Components
Price: AED 4400.0
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Cancer
Doctor
Oncologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for Breast Comprehensive Panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABRAXAS1, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, FANCC, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS1, PMS2, PTEN, RAD50, RAD51C, RAD51D, RECQL, SMARCA4, STK11, TP53, XRCC2
Test Details
Breast comprehensive panel NGS genetic DNA test is a type of genetic test that analyzes specific genes associated with breast cancer. This panel test uses next-generation sequencing (NGS) technology to examine multiple genes simultaneously, providing a more comprehensive analysis than traditional single-gene tests.
The breast comprehensive panel NGS genetic DNA test can identify mutations in genes such as BRCA1 and BRCA2, which are associated with an increased risk of developing breast and ovarian cancer. Other genes analyzed in this panel may include ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, and RAD51D.
This test is typically recommended for individuals with a personal or family history of breast cancer, particularly if there are multiple cases of breast or ovarian cancer in the family, early onset of breast cancer, or male breast cancer. The results of this test can help inform medical management decisions, such as increased surveillance or risk-reducing surgeries.
It is important to note that not all genetic mutations identified by this test are definitively associated with an increased risk of breast cancer, and the interpretation of test results should be done in consultation with a healthcare provider trained in genetics.
Test Name | Breast comprehensive panel NGS Genetic DNA Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for Breast comprehensive panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABRAXAS1, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, FANCC, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS1, PMS2, PTEN, RAD50, RAD51C, RAD51D, RECQL, SMARCA4, STK11, TP53, XRCC2 |
Test Details | Breast comprehensive panel NGS genetic DNA test is a type of genetic test that analyzes specific genes associated with breast cancer. This panel test uses next-generation sequencing (NGS) technology to examine multiple genes simultaneously, providing a more comprehensive analysis than traditional single-gene tests. The breast comprehensive panel NGS genetic DNA test can identify mutations in genes such as BRCA1 and BRCA2, which are associated with an increased risk of developing breast and ovarian cancer. Other genes analyzed in this panel may include ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, and RAD51D. This test is typically recommended for individuals with a personal or family history of breast cancer, particularly if there are multiple cases of breast or ovarian cancer in the family, early onset of breast cancer, or male breast cancer. The results of this test can help inform medical management decisions, such as increased surveillance or risk-reducing surgeries. It is important to note that not all genetic mutations identified by this test are definitively associated with an increased risk of breast cancer, and the interpretation of test results should be done in consultation with a healthcare provider trained in genetics. |